Tatiana Nanda

Head Of Cell & Gene Analytical Development And Cell Therapy Process Development at Center for Breakthrough Medicines

Tatiana Nanda has a diverse and extensive work experience in the field of biopharmaceuticals and gene and cell therapy. Tatiana is currently the Head of Process Development - Cell Therapy, Drug Product and Process Analytics at the Center for Breakthrough Medicines. In this role, they lead the efforts of the CMC teams for various modalities of gene therapy and integrates expertise in cell and gene therapy into a unified DP team.

Prior to their current position, Tatiana worked at Janssen Inc. as an Associate Director, where they managed the delivery of oncology assets in various modalities and provided end-to-end management of development and commercialization activities for blockbuster oncology biologics.

Tatiana also has experience at GlaxoSmithKline, where they served as a Biopharmaceutical Product Development Investigator/MPD Manager and Principal Scientist. In these roles, they led global CMC teams, managed in-licensed biopharmaceutical projects, and supported drug product development and manufacturing.

Tatiana began their career as a Graduate Research Assistant at the University of Tennessee Medical Center, where they conducted research on protein aggregation and its implications in Huntington Disease.

Overall, Tatiana Nanda's work experience demonstrates their expertise in biopharmaceutical development, project management, and the integration of gene and cell therapy into drug product development.

Tatiana Nanda holds a diverse education history. Tatiana obtained their Bachelor of Science (BS) degree in Microbiology and Computational Genomics from the University of Tennessee, Knoxville, between 2006 and 2008. Following this, they pursued their Doctor of Philosophy (PhD) degree in Biochemistry, Biophysics, and Molecular Biology at the UT/ORNL Graduate School of Genome Science and Technology from 2009 to 2012.

In addition to their previous degrees, Tatiana Nanda acquired a certification in Business Analytics from The Wharton School, Aresty Institute of Executive Education in September 2020.

Before pursuing their scientific education, Tatiana Nanda studied Economics at Lomonosov Moscow State University (MSU) from 1998 to 2002. The degree attained from MSU has not been specified in the available information.

Links

Previous companies

University of Delaware logo

Timeline

  • Head Of Cell & Gene Analytical Development And Cell Therapy Process Development

    September 1, 2023 - present

  • Head Of Process Development Cell Therapy Drug Product And Process Analytics

    January, 2022

  • Director Program Leader

    April, 2021

View in org chart